Is Compounded Tirzepatide Still Available?

Yes. Compounded tirzepatide is still available in 2026 with a prescription, but not on the terms women got used to during the shortage. FDA declared the tirzepatide shortage resolved in December 2024. Since then, a state-licensed pharmacy can compound tirzepatide for an individual patient once it receives a prescription, and FDA restricts routine copies of Zepbound unless the prescriber documents a significant difference for that patient. Many telehealth companies were still listing compounded tirzepatide in August 2026, according to a price index of 13 US telehealth providers.

The questions to ask now are who prescribes it, which pharmacy makes it, how you dose it and what it costs next to brand Zepbound.

Why did people think compounded tirzepatide was going away?

Compounded tirzepatide became common because the brand drug ran short. FDA said tirzepatide injection had been in shortage since 2022 because of increased demand. While a drug sits on FDA's shortage list, pharmacies are allowed to make near-identical copies of it.

On December 19, 2024, FDA declared the tirzepatide shortage resolved. Once a shortage ends, FDA generally treats the brand drug as commercially available again, which limits copying it.

Compounders sued to keep the shortage status. A court denied their request on March 5, 2025. The grace period for regular compounding pharmacies ended, and outsourcing facilities had until March 19, 2025.

That is why the headlines said compounded tirzepatide was ending. What ended was mass copying during a shortage. Prescribing compounded tirzepatide for an individual woman did not end.

How can a pharmacy still make compounded tirzepatide in 2026?

A regular state-licensed compounding pharmacy (called a 503A pharmacy) can make tirzepatide for an individual patient once it receives a prescription. An outsourcing facility (called a 503B facility) is restricted from making it from bulk ingredient.

The limits on copies matter for what lands in your fridge. FDA counts a compounded drug as "essentially a copy" of Zepbound if it has the same active ingredient, in the same, similar or an easily substitutable strength, and is given the same way. The exception is when the prescriber determines and documents that the compounded version has a change that makes a significant difference for that specific patient. Pharmacies cannot make copies regularly or in large amounts. FDA says it does not intend to act against a pharmacy that fills four or fewer prescriptions of a copy in a calendar month.

Adding an extra ingredient does not automatically make a product different. FDA has said a semaglutide-plus-B12 product may still count as a copy.

Some comparison sites still tell you to look for a 503B outsourcing facility. That advice is out of date for tirzepatide.

How much does compounded tirzepatide cost compared with Zepbound?

Compounded tirzepatide plans in Astra's tirzepatide price index ran from $118 a month on an annual plan to $499 a month at standard pricing. Brand Zepbound from LillyDirect was a flat $299 a month self-pay. Astra publishes the index and also sells compounded tirzepatide.

Published prices from Astra's index:

When you compare plans, look at the monthly price after membership, shipping and the renewal rate, not the promo number. Some low prices rise after the first month or require you to pay for several months up front.

Brand Zepbound now costs about as much as many compounded plans. Price alone should not decide between compounded and brand tirzepatide. Choose compounded tirzepatide when your clinical team decides it fits you.

Is compounded tirzepatide safe to use?

Compounded tirzepatide is prescribed by a clinician, made by a state-licensed pharmacy, and usually drawn up by you at home. It does carry risks that brand Zepbound does not. Compounded drugs are not FDA-approved, so they do not go through FDA's review of safety, effectiveness and quality the way Zepbound did.

The big weight-loss results come from brand tirzepatide trials. In SURMOUNT-5, people on the 15 mg dose lost an average of 20.2% of their body weight at 72 weeks. Compounded versions were not the drug tested in those trials.

In FDA's adverse event reports from 2018 to 2024, 707 of 81,078 GLP-1 reports involved compounded semaglutide, tirzepatide or liraglutide. Those reports were more likely than reports for brand products to mention hospitalization (reporting odds ratio 2.35), contamination (19.00) and preparation errors (48.92). The study cannot show that compounding caused these problems.

Dosing is the part you control. Compounded tirzepatide usually comes in a multi-dose vial you draw up yourself, rather than a prefilled pen. FDA has warned about patients "mistakenly drawing up more than the prescribed dose from a multiple-dose vial," so have your clinical team show you your dose in syringe units before your first shot.

One Reddit user wondered whether the pharmacy matters: "I always wondered why compounded tirzepatide can feel or work a little differently depending on which pharmacy makes it."

How do I get compounded tirzepatide the right way?

Get compounded tirzepatide through a clinician who prescribes it for you and a state-licensed pharmacy you can name. Then plan for follow-up.

• Have a clinician review your health history first. Some reasons not to take tirzepatide, such as a family history of medullary thyroid cancer or multiple endocrine neoplasia type 2, need a clinician to check.
• Ask which state-licensed pharmacy makes your tirzepatide. Nearly half of online pharmacies offering semaglutide may be operating illegally, running nondelivery scams or selling products that do not meet quality standards. Those sellers are not the same as legitimate state-licensed pharmacies.
• Walk away from any seller that calls compounded tirzepatide "FDA approved" or "Proven Weight Loss." In February 2026, FDA sent a warning letter to a telehealth seller that called its compounded tirzepatide "FDA approved and clinically proven to work" and "Proven Weight Loss." FDA cited those claims as false or misleading.
• Plan for follow-up, not one prescription. A 65-year-old woman on compounded tirzepatide wrote: "Weight initially dropped 40 lbs and for 3.5 years stabilized in a BPI of 22-low 23." She later saw her numbers creep up and wanted to talk about dose changes. That is a conversation to have with your clinical team.
• Start with a team that can prescribe. Our clinical team can prescribe tirzepatide if it fits your goal and your health history.

You want to lose the weight with a prescription you can trust. Take the quiz so our clinical team can see whether tirzepatide fits your goal and your health history.